NanoBio To Develop Vaccine For Treatment Of Hepatitis B
ANN ARBOR - NanoBio Corporation Monday announced an initiative to develop an intranasal vaccine for the treatment of hepatitis B (HBV). NanoBio and the University of Michigan's, Michigan Nanotechnology Institute for Medicine and Biological Sciences received funding through a Phase 1 Technology Transfer award by the National Institutes of Health (NIH), to evaluate a potential